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ABSTRACT 
MiR-140 is selectively expressed in cartilage. Deletion of the entire miR-140 locus in mice 
results in growth retardation and early-onset osteoarthritis-like pathology, however the 
relative contribution of miR-140-5p or miR-140-3p to the phenotype remains to be 
determined. An unbiased small RNA sequencing approach identified miR-140-3p as 
significantly more abundant (>10-fold) than miR-140-5p in human cartilage. Analysis of 
these data identified multiple miR-140-3p isomiRs differing from the miRBase annotation at 
both the 5´ and 3´ end, with >99% having one of two seed sequences (5´ bases 2-8).  
Canonical (miR-140-3p.2) and shifted (miR-140-3p.1) seed isomiRs were overexpressed in 
chondrocytes and transcriptomics performed to identify targets. miR-140-3p.1 and miR-140-
3p.2 significantly downregulated 694 and 238 genes respectively, of which only 162 genes 
were commonly downregulated. IsomiR targets were validated using 3 ´UTR luciferase 
assays. miR-140-3p.1 targets were enriched within upregulated genes in rib chondrocytes of 
Mir140-null mice and within downregulated genes during human chondrogenesis. Finally, 
through imputing the expression of miR-140 from the expression of the host gene WWP2 in 
124 previously published datasets, an inverse correlation with miR-140-3p.1 predicted 
targets was identified. Together these data suggest the novel seed containing isomiR miR-
140-3p.1 is more functional than original consensus miR-140-3p seed containing isomiR.  
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INTRODUCTION 
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression. Mature 
miRNAs are processed from primary transcripts containing stem loops by cleavage mediated 
by Drosha and then Dicer proteins (Bartel 2004). The 5´ and 3´ sides of the stem loop can 
both give rise to mature miRNAs termed ´-5p´ and ´-3p´ respectively (Griffiths-Jones 2004). 
These mature miRNAs are then loaded into the RNA-induced silencing complex (RISC) to 
mediate either mRNA degradation or translation inhibition of target mRNA through binding 
of the miRNA seed sequence (5´ bases 2-8) to the target 3´UTR (Bartel 2009). The level of 
complementarity between the seed and target mRNA is important for target repression. 
Binding to positions 2-7 of the miRNA may indicate target repression, however either an 
adenine binding to position 1 of the miRNA (7a1 targets), a match at position 8 (7m8 
targets) or both (8mer targets) can improve target repression (Lewis et al. 2005). 
In recent years, small RNA (sRNA) sequencing (sRNA-seq) has identified additional miRNAs 
that do not perfectly align to the annotated mature miRNA, known as isomiRs (Morin et al. 
2008). IsomiRs may be shorter or longer at the 5´ and/or 3´ end of the mature miRNA, and 
are not always templated to the genomic DNA. Variants at the 3´ end are quite common, 
although not thought to alter the miRNA target repertoire (Wyman et al. 2011). Variations 
at the 5´ end are less common but are of greater importance due to altered seed sequence, 
target repertoire and potentially the function of miRNAs. The type of 5´isomiR variation is 
critical for determining the consequence on target repertoire, for example 5’ isomiRs of 
microRNAs can have highly over-lapping (Cloonan et al. 2011; Llorens et al. 2013) or 
divergent (Tan et al. 2014) targets, which is dependent upon the presence or absence of a 
uracil (U) at position 2 of the longer sequence (Manzano et al. 2015). 
The most studied miRNA in cartilage is miR-140, which produces miR-140-5p and miR-140-
3p (Wienholds et al. 2005; Miyaki et al. 2009; Miyaki et al. 2010). Deletion of Mir140 in mice 
leads to a skeletal phenotype including an osteoarthritis (OA)-like disease. Although the 
contribution of the lack of miR-140-5p or miR-140-3p to the phenotype remains largely 
undetermined, the majority of studies have focused on miR-140-5p rather than miR-140-3p 
(Wienholds et al. 2005; Miyaki et al. 2009; Miyaki et al. 2010), with the reason behind this -
5p bias unclear. Barter et al. showed a particularly important role for miR-140-5p during 
human chondrogenesis with many genes under its control, and although they used a 
systematic approach, they did not include isomiRs within their analysis (Barter et al. 2015). 
miR-140-3p is less well studied than miR-140-5p and only a small number of -3p targets 
have been identified, which so far appear to have little relevance to cartilage and OA. 
Intriguingly, using small RNA sequencing (sRNA-seq) of human cartilage RNA we identified 
that miR-140-3p was high in abundance (>10-fold) compared to miR-140-5p (Crowe et al. 
2016).  
Although there have been several studies to elucidate the role of miRNAs in cartilage and 
chondrogenesis, the role of isomiRs has been largely ignored. Here we show miR-140-3p 
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isomiRs are abundantly expressed in cartilage and that these isomiRs are present in RISC. 
Using over expression followed by transcriptomic analysis we show two miR-140-3p isomiRs 
(miR-140-3p.1 and miR-140-3p.2) have largely discrete target repertoires. We validated a 
number of common and discrete targets for each isomiR using a luciferase reporter system. 
We present evidence that miR-140-3p.1, which is not currently annotated in miRBase, may 
play roles in human chondrogenesis, mouse cartilage and in multiple other skeletal tissues.   
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MATERIAL AND METHODS 
Analysis of cartilage sRNA-seq 
sRNA-seq was analysed as previously described (Sorefan et al. 2012; Crowe et al. 2016). 5´ 
isomiRs were defined using the following criteria: 1) loss or gain of 1 or more nucleotides, 
using the mature miRBase (release 22.1) (Kozomara and Griffiths-Jones 2011) sequences as 
a reference;  2) a read count >100, and 3) a read count > 5% of the mature miRBase 
reference sequence for that miRNA.  
 
Analysis of non-cartilage sRNA-seq 
Read count for non-cartilage sRNA-seq including; melanoma (Stark et al. 2010 (Stark et al. 
2010)), cervix (Witten et al. 2010 (Witten et al. 2010)), lymphocytes (Kuchen et al. 2010 
(Kuchen et al. 2010)) was obtained from miRBase (Kozomara and Griffiths-Jones 2011), or 
directly from publication for sRNA-seq following immunoprecipitation of Argonaute (AGO) 
proteins (Burroughs et al. (Burroughs et al. 2011)). Sequences were designated as either 
miR-140-3p.1 or miR-140-3p.2 based upon seed sequence.  For the analysis, mouse cortex 
CLEAR (covalent ligation of endogenous Argonaute-bound RNAs)-CLIP data (NCBI GEO 
GSE73059) was analysed as previously described (Moore et al. 2015) using the parameters 
provided. Briefly, the reads were quality filtered, duplicate reads collapsed, trimmed and 
the barcodes stripped using the CLIP Tool kit (Shah et al. 2017). The TargetScanMouse 7.2 
miRNA database was mapped against each sample (treated as a reference genome) using 
Bowtie (v1.0.0). miRNA-first chimeric reads uniquely assignable to the miR-140 isomiRs 
were identified in R, potential PCR duplicates with the same degenerate barcode were 
collapsed and filtered to retain reads with chimeric mRNA sequences >20nt in length. 
 
Human articular chondrocyte isolation, culture and transfection 
Human articular chondrocyte isolation from knee cartilage was performed as previously 
described (Barter et al. 2015). Tissue was donated by patients with diagnosed osteoarthritis 
and undergoing joint replacement surgery, with informed consent and ethics committee 
approval. Briefly, macroscopically normal cartilage was removed from the subchondral bone 
and dissected into ~1mm pieces using scalpel and forceps. Enzymatic digestion was 
performed using trypsin and then collagenase overnight at 37oC. Chondrocytes were then 
grown to confluence and plated into 6 well plates for miRNA/isomiR mimic transfection.  
100nM miRNA mimic and control were transfected into HAC using DharmaFECT 1 
transfection reagent (Dharmacon, Horizon Discovery, Cambridge, UK) according to the 
manufacturer’s protocol and essentially as previously described (Barter et al. 2015). 48h 
post-transfection HAC were lysed and RNA harvested using Qiagen miRNeasy kit (Qiagen, 
Crawley, UK). Custom miRNA mimics with each isomiR sequence were purchased from 
Dharmacon, standard (A4) desalted purification. 
 
Microarray and identification of targets in human chondrocytes  
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Microarray was performed by Cardiff University, Central Biotechnology Services, using 
Illumina whole‐genome expression array Human HT‐12 V4 (Illumina, Saffron Walden, U.K.). 
Normalization of the quantified signals (background corrected) was performed using the 
global Lowess regression algorithm. Expression analysis was performed in R/bioconductor 
using the limma package (Smyth 2004). PCA and heat map were generated using ClustVis 
(Metsalu and Vilo 2015). PCA analysis was performed on normalised expression values of all 
unique genes detected by the microarray analysis. Data was not transformed; row scaling 
was unit variance and the PCA method selected was singular value decomposition (SVD) 
with computation. Heat map is based on the top 650 significant genes for each comparison 
(miC vs. mR-140-3p.1 or miC vs. miR-140-3p.2), which after removal of duplicates gave 882 
genes in total. Clustered distance was based on correlation with the method set to average. 
TargetScanHuman (version 7.2 (Agarwal et al. 2015a)) was used to predict targets of miR-
140-3p.1 and miR-140-3p.2. In order to demonstrate discrete functions we investigated 
unique targets for each isomiR (3p.2 and 5p targets were removed from 3p.1 analysis; 3p.1 
and 5p targets were removed from 3p.1 analysis; 3p.1 and 3p.2 targets were removed from 
5p analysis). Genes were selected for luciferase validation based on both altered expression 
in miR-140-3p.1 or miR-140-3p.2 transfected cells versus control and on expression in miR-
140-3p.1 transfected cells versus expression in miR-140-3p.2 transfected cells.  
 
Target enrichment and pathway analysis  
Sylamer analysis was performed on ordered gene lists from most downregulated to most 
upregulated (including genes whose expression did not significantly change) (van Dongen et 
al. 2008). Target enrichment (%targets) was calculated by dividing the total number of 
predicted targets (TargetScan 7.2) that significantly increased or decreased by the total 
number of genes that significantly increased or decreased, multiplied by 100. Cumulative 
fraction plots were generated as previously described (Woods et al. 2019), using ordered 
gene list from downregulated to most upregulated (regardless of significance) and predicted 
targets from TargetScan 7.2. Pathway analysis was performed using Database for 
Annotation, Visualization and Integrated Discovery (DAVID) v6.7(Huang da et al. 2009) and 
g-Profiler (Raudvere et al. 2019). 
 
Q-RT-PCR for miR-140-3p.1 and miR-140-3p.2 
Custom miR-140-3p.1 and miR-140-3p.2 assays (Exiqon, Qiagen, Aarhus, Denmark) were 
used to detect expression of miR-140-3p.1 and miR-140-3p.2. Assays were validated using 
spike-in of miR-140-3p.1 and miR-140-3p.2 mimic (Dharmacon).   
 
3´UTR luciferase reporter construction and assay 
In-Fusion® cloning (Clontech, Takara Bio Europe SAS, Saint-Germain-en-Laye, France) of 
selected 3´UTRs into the pmirGLO vector (Promega, Southampton, UK) was used to 
generate 3´UTR luciferase reporters essentially as previously described (Barter et al. 2015) 
(Supplementary Table 10). SW1353 chondrosarcoma cells were seeded and cultured to 
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reach ~50% confluence after 24 h (Barter et al. 2015). miRNA (100 nM) were transfected 
using DharmaFECT 1 transfection reagent, reporter plasmids (500 ng/ml) were transfected 
using FugeneHD (Promega). 24h after transfection luciferase levels determined using 
Promega dual luciferase assay and GloMax plate reader (Promega).  
 
Generation of miR-140-/- mice 
All animal experiments were performed under licenses granted from the Home Office 
(United Kingdom) in accordance with the guidelines and regulations for the care and use of 
laboratory animals outlined by the Animals (Scientific Procedures) Act 1986 according to 
Directive 2010/63/EU of the European Parliament, and conducted according to protocols 
approved by the Animal Ethics Committee of Newcastle University and the Home Office, 
United Kingdom.  Post-generation breeding and subsequent phenotyping were performed 
under licences PPL60/4525 and P8A8B649A. CRISPR/Cas9 guide RNAs (crRNA) were 
designed using CHOPCHOP. crRNA linked with TRACR (sgRNA) were amplified by PCR with a 
pLKO vector (Addgene_52628) as template, using the primer T7 TRACR R (Supplementary 
Table 10) and a 5´ PCR primer that included a T7 sequence and the crRNA. This was 
converted to RNA using the MEGAshortscript T7 kit (Fisher Scientific). sgRNA (50ng/ml each) 
were mixed with recombinant Cas9 (ToolGen, CamBioScience Limited, Cambridge, UK) and 
injected into the cytoplasm of donor mouse zygotes and transferred into recipient foster 
mothers, all essentially as previously described (Ittner and Gotz 2007; Ran et al. 2013; Yang 
et al. 2013). The mixed C57BL/6 and CBA/ca F0 mice were backcrossed onto C57BL/6J and 
heterozygous animals crossed three times to eventually generate wild-type and null lines 
used in purification of rib chondrocytes. Genotype was confirmed by ear-notch PCR and 
Sanger sequencing (Supplementary Figure S5). 
 
Mouse rib chondrocyte isolation and RNA-seq 
Primary mouse costal chondrocytes were isolated from 7-day-old miR-140-/- and wild-type 
(WT) mice using collagenase digestion, essentially as previously described (Grigelioniene et 
al. 2019a). Total RNA, including miRNA was isolated using the miRVana miRNA Isolation Kit 
(with phenol)( Fisher Scientific). Sequencing libraries were prepared from 500 ng of purified 
total RNA using the Illumina TruSeq Stranded mRNA sample preparation kit according to the 
manufacturer’s protocol, and sequenced on Illumina NextSeq500. Each sample provided >12 
million single-end 75-bp sequencing reads. Sequenced reads were mapped to the mm10 
transcriptome using Salmon (Patro et al. 2017).  Batch effects were estimated using RUVseq 
(Risso et al. 2014) and incorporated into the differential expression analysis performed using 
DESeq2 (Love et al. 2014).  PCA and heat map were generated using ClustVis (Metsalu and 
Vilo 2015) using the parameters defined above, using all transcripts for the PCA and the top 
1200 significant transcripts based on p-value for the heatmap.  
 
Analysis of human MSC chondrogenesis  
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Microarray data of human MSC chondrogenesis was previously published by Barter et el. 
(Barter et al. 2015). Data was re-analysed for changes in expression of miR-140-3p.1 and 
miR-140-3p.2 predicted targets, lists of conserved predicted targets were obtained from 
TargetScan (version 7.2). Enrichment for 7m8 seed sequence binding sites was performed 
using Sylamer (van Dongen et al. 2008).  
 
 
SkeletalVis analysis  
Gene expression responses within SkeletalVis were filtered for human and mouse data sets 
and where WWP2 expression significantly changed (adjusted p-value is <0.05, no fold 
change cut off), leaving 124 experimental comparisons. The change in WWP2 expression 
was plotted against the average fold change of predicted (TargetScan7.2) miRNA targets for 
each experimental comparison. Correlation (R2) and regression analysis for all 124 
experimental comparisons was calculated using the data analysis add-in in Microsoft Excel. 
The percentage (% of miRNA targets) was calculated by dividing the total number of 
predicted targets (TargetScan 7.2) that significantly increased or decreased by the total 
number of genes that significantly increased or decreased, multiplied by 100, for each of the 
124 experimental comparisons. The percentage of miR-140-5p, miR-140-3p.1 and miR-140-
3p.2predicted targets within up-, no change or downregulated genes was then plotted 
against log2 FC for WWP2, the trend lines represent the cumulative mean starting from 
studies where WWP2 is most up- or downregulated to studies where WWP2 changes least, 
to demonstrate trend. A list of randomly generated genes was analysed alongside miR-140-
5p, miR-140-3p.1 and miR-140-3p.2. ‘Targets Enrichment (up/down)’ was calculated by 
dividing the ‘% of miRNA targets within up-regulate genes’ by the ‘% of miRNA targets 
within downregulated genes’, this was performed for each miRNA in each study. The mean 
‘Target enrichment (up/down)’ for studies where WWP2 either decreased or increased was 
plotted.   ‘Targets Enrichment (up/down)’  for  miR-140-5p, miR-140-3p.1 and miR-140-3p.2 
predicted targets was also plotted against each other. Experimental comparisons where 
WWP2 decreased or increased were shown in different colours as described.  
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RESULTS 
RNA-Seq of articular cartilage identifies an overabundance of miR-140-3p and miR-140-3p 
isomiRs  
We performed sRNA-seq of human cartilage RNA and identified novel cartilage specific 
miRNAs (Crowe et al. 2016). Our cartilage sRNA-seq aligned to 990 miRNAs annotated in 
miRBase (Kozomara and Griffiths-Jones 2011), 704 of which contained at least one 
additional type of potential isomiR (Supplemental Table S1). As 5´ isomiRs are most likely to 
alter function, we focused further sRNA-seq analysis on miRNAs with 5´isomiRs. Using 
thresholds of >100 reads and >5% of total reads for that miRNA, we identified 5´isomiR 
sequences for 29 miRNAs, 26 of which have a single addition (includes templated and non-
templated additions) or deletion at the 5´ nucleotide, while miR-3074-5p, miR-455-3p and 
let-7b-3p all have two additional 5´ nucleotides (Supplemental Figure S1). Although the 
isomiR for miR-1246 is just under our read threshold (read count of 99), it appears to have 
four additional 5´ nucleotides compared to the miRBase annotation (Supplemental Figure 
S1).  
MiR-140-3p and its isomiRs account for more than half of all sequencing reads in our 
cartilage sRNA-seq (Figure 1A). As miR-140 is the most studied cartilage miRNA, yet most 
attention has been paid to miR-140-5p, this report will focus on mirR-140-3p and its 
isomiRs. IsomiRs can be sub-divided into several categories, essentially either templated or 
non-templated with either 5´ or 3´ modifications (Cloonan et al. 2011). miR-140-3p isomiRs 
are predominantly 3´ additions and mixed type isomiRs, with only 5% aligning to the original 
miRBase annotation (Figure 1B). More than 99% of all miR-140-3p isomiRs result in one of 
two seed sequences; ACCACAG as annotated in miRBase, and CCACAGG, which is shifted by 
-1 nucleotide (shifted by one nucleotide in the 3´ direction) (Figure 1C). Twenty-five percent 
of reads for miR-140-3p were perfectly templated to DNA (Figure 1D), the remainder 
contained one or more non-templated nucleotides, predominantly non-templated 3´ 
adenine additions (Figure 1E), which were observed in sequencing reads containing both of 
the seed sequences (Figure 1F and G). The most detected isomiR with each seed are termed 
miR-140-3p.1 (ACCACAGGGTAGAACCACGGAC, seed CCACAGG) and miR-140-3p.2 
(TACCACAGGGTAGAACCACGGA seed: ACCACAG), respectively (Figure 1H). Expression of 
miR-140-3p.1 and miR-140-3p.2 in cartilage (performed with a 2-fold serial dilution) was 
validated using qRT-PCR with isomiR selective assays (Figure 1I).  
Analysis of other published sRNA-seq data identified the presence of miR-140-3p.1 and miR-
140-3p.2 in other human tissue types, although expressed at a lower level than in cartilage 
(Supplemental Figure S2) (Kuchen et al. 2010; Stark et al. 2010; Witten et al. 2010). As 
miRNA bound to Argonaute (AGO) indicates the ability to repress targets (Flores et al. 2014), 
we analysed sRNA-seq data following immunoprecipitation of AGO proteins (Burroughs et 
al. 2011). Indeed, both miR-140-3p.1 and miR-140-3p.2 were present (RISC; Supplemental 
figure S2). Furthermore analysis of CLEAR-CLIP, a modified version of high-throughput 
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sequencing of RNA isolated by crosslinking immunoprecipitation  (HITS-CLIP), from mouse 
brain (Moore et al. 2015), identified sequences corresponding to both miR-140-3p.1 and 
miR-140-3p.2 ligated to endogenous mRNA potential targets (Supplemental Figure S2). 
Together these data indicate miR-140-3p.1 and miR-140-3p.2 can be loaded into RNA-
induced silencing complex and can target transcripts. 
miR-140-3p.1 and miR-140-3p.2 are predicted to have distinct targets  
miRNAs generally target mRNAs through interaction of their seed sequence (nucleotides 2-
7), the seed sequences for miR-140-3p.1 and miR-140-3p.2 differ (CCACAGG and ACCACAG, 
respectively; Figure 2A). Thus, each miR-140-3p isomiR has different preferences for seed 
binding sites (Figure 2A). Indeed, target prediction analysis for miR-140-3p.1 and miR-140-
3p.2 by TargetScan 7.2 (conserved) identifies only 133 shared targets, a small number 
compared to the total number of predicted targets (665 and 495 for miR-140-3p.1 and miR-
140-3p.2, respectively, Figure 2B, Supplemental Table S2). The majority of these targets also 
differ from predicted miR-140-5p targets (Figure 2B, Supplemental Table S2).  
 
Identification and validation of miR-140-3p.1 and miR-140-3p.2 targets in human 
chondrocytes  
Next, we used overexpression of miR-140-3p.1 and miR-140-3p.2 in primary human 
chondrocytes followed by genome-wide transcriptomics to experimentally identify 
similarities and differences in their target repertoire. Overexpression of miR-140-3p.1 and 
miR-140-3p.2 was validated using isomiR-specific qRT-PCR (Figure 3A). Principal component 
analysis (PCA) and heat map illustrated clustering of biological replicates and differences 
between miR-140-3p.1 and miR-140-3p.2 in transfected chondrocytes (Figure 3B and C). 693 
and 237 genes were significantly (adjusted p-value<0.05) downregulated by miR-140-3p.1 
and miR-140-3p.2 respectively, however only 161 genes were commonly downregulated by 
both isomiRs (compared to control; Figure 3D, Supplemental Table S3, Supplemental Table 
S4). DAVID pathway analysis of repressed genes identified enrichment terms associated 
with ‘phosphoprotein’ for miR-140-3p.1 (Supplemental Table S5). Direct comparison of miR-
140-3p.1 transfected with miR-140-3p.2 transfected cells revealed 237 genes were 
significantly different between the two isomiRs (Supplemental Table S3, Supplemental Table 
S4). DAVID pathway analysis of the 237 genes differentially expressed between the two 
isomiRs identified an enrichment of triple helical collagen genes (COL2A1, COL4A1, COL6A3, 
COL11A1, COL11A2; p=0.0004, adjusted p-value=0.066; Supplemental Table S5). Similarly, g-
Profiler analysis of genes differentially expressed between miR-140-3p.1 and miR-140-3p.2 
transfected chondrocytes, revealed an enrichment of genes associated with ECM structure 
including ‘connective tissue development’ (adjusted p-value 0.005; Supplemental Figure S3). 
The fraction of these genes that are decreased by, and are predicted to be a targets of each 
isomiR, is greater for miR-140-3p.1 than for miR-140-3p.2, suggesting miR-140-3p.1 directly 
regulates genes belonging to these terms. However, the majority of genes contributing to 
the enrichment are not predicted direct targets of either miR-140-3p.1 or miR-140-3p.2, 
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suggesting miR-140-3p isomiRs, in the most part, regulate these processes through indirect 
mechanisms. Together these data indicate that the sequence differences between the two 
isomiRs may be functionally important.       
 
Sylamer, a non-bias motif analysis tool, was used to investigate miRNA binding site 
enrichment within downregulated 3´UTRs (van Dongen et al. 2008). Transfection of either 
miR-140-3p.1 or miR-140-3p.2, showed specific enrichment for 8mer, 7m8, 7a1 and 6mer 
seed binding sites of the transfected isomiR. Interestingly, a greater enrichment was 
observed for miR-140-3p.1 (non-canonical seed) binding sites than miR-140-3p.2 (canonical 
seed) binding sites (Figure 3E). Predicted targets (identified using TargetScan 7.2) that are 
unique to either miR-140-3p.1 or miR-140-3p.2 were downregulated following 
overexpression of either miR-140-3p.1 or miR-140-3p.2 respectively, but not downregulated 
by the reciprocal isomiR (Figure 3F), suggesting both isomiRs can repress specific transcripts 
in human chondrocytes.   
 
Based upon expression of individual genes (Supplemental Table S3), unique and common 
targets were then selected for 3´UTR luciferase validation (Figure 3G-I). As expected LIPA, 
RCL1, COL4A1 and SLC35D2 were validated as miR-140-3p.1 targets; NUDT21, REEP5 and 
SDC4 were validated as miR-140-3p.2 targets and PAX2 validated as a target of both miR-
140-3p.1 and miR-140-3p.2. Interestingly, the REEP5 3´UTR luciferase construct was also 
repressed by miR-140-3p.1, although not a predicted target of miR-140-3p.1. Conversely, 
DAAM1 and ALDH1A3 are predicted targets of both miR-140-3p.1 and miR-140-3p.2, 
however significant repression was only observed for miR-140-3p.1 and not for miR-140-
3p.2. Contrary to the repression role of miRNAs in gene regulation, miR-140-3p.1 increased 
luciferase for the MARCKSL1, KIAA1199 and MAPILC3A 3´UTR reporters.  
 
miR-140-3p isomiRs are functional in mouse cartilage  
Analysis of mouse sRNA-Seq data revealed that both miR-140-3p.1 and miR-140-3p.2 are 
present (Figure 4A-C) and more abundant than miR-140-5p (Chiang et al. 2010) 
(Supplemental Figure S4A), indicating miR-140-3p 5´ isomiRs are conserved across species, 
although there are some differences in abundance of 3´ variations. We and others have 
generated Mir140-null mice, which lack all miRNAs and isomiRs produced from the Mir140 
locus (Supplemental Figure S5). Transcriptome RNAseq data of rib cartilage from these mice 
identified 1894 and 1179 genes that were significantly up and downregulated respectively 
(Supplemental Table S6, Supplemental Table S7). Pathway analysis of upregulated genes 
following knock out (KO) of Mir140 identified terms associated with ‘phosphoprotein’ 
(Supplemental Table S8), which is consistent with pathway analysis of genes decreased 
following miR-140-3p.1 overexpression in human chondrocytes (Supplemental Table S5). 
miR-140-5p, miR-140-3p.1 and miR-140-3p.2 predicted targets (identified using TargetScan 
7.2) were enriched within upregulated genes (Figure 4D), and their average expression 
increased following KO of the Mir140 locus (Figure 4E), indicating a loss of target repression. 
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Furthermore, cumulative fraction plot analysis indicates that the fraction of targets that 
decrease following KO of the Mir140 locus is lower than expected (Figure 4F). Non-biased 
Sylamer analysis also identified an enrichment of miR-140-5p, miR-140-3p.1 and miR-140-
3p.2 7m8 seed binding sites within upregulated genes; miR-140-5p displayed the greatest 
enrichment, followed by miR-140-3p.1 and then miR-140-3p.2 (Figure 4G).  
 
More than 99% of miRNAs produced from the murine Mir140 locus share seed binding sites 
with either miR-140-5p, miR-140-3p.1 or miR-140-3p.2; of these miR-140-5p has the lowest 
read count, yet has the largest contribution to target repression (Figure 4). We used Sylamer 
to investigate the possibility that other lowly expressed sequences produced from the 
Mir140 stem loop (Supplemental Figure S4A), may contribute to target repression. This 
analysis indicates miR-140-5p followed by miR-140-3p.1 have the largest contribution to 
target repression in mir140 KO mice (Supplemental Figure S4B), and that there are no lowly 
expressed Mir140-derived miRNAs that have a major contribution to target repression in 
mice. 
 
miR-140-3p.1 targets are enriched within downregulated genes during MSC 
chondrogenesis 
miR-140 is highly upregulated during mesenchymal stem cell (MSC) chondrogenesis, with 
miR-140-5p predicted targets highly enriched within the downregulated genes (Barter et al. 
2015). Here we show through re-analysis of this transcriptomic dataset (Figure 5A) that 
expression of predicted targets of both miR-140-3p.1 and miR-140-3p.2 are decreased 
during chondrogenesis. Similar to miR-140-5p predicted targets, the average expression of 
miR-140-3p.1 and miR-140-3p.2 predicted targets decreased during chondrogenesis, with 
unique miR-140-3p.1 targets being more repressed than unique miR-140-3p.2 predicted 
targets (p=0.07) (Figure 5B). Sylamer analysis indicated enrichment for miR-140-5p and miR-
140-3p.1, but minimal enrichment for miR-140-3p.2 (Figure 5C). Consistent with Mir140 null 
mouse data, the enrichment of miR-140-5p was greater than for both miR-140-3p.1 and 
miR-140-3p.2 in genes whose expression decreased during human MSC chondrogenesis 
(Figure 5C).  
 
miR-140-5p and miR-140-3p.1 predicted targets inversely correlate with WWP2 in multiple 
skeletal tissues 
Having established miR-140-5p, miR-140-3p.1 and miR-140-3p.2 targets are regulated 
during human MSC chondrogenesis and in mouse rib chondrocyte development, we next 
looked for evidence of an inverse correlation between miR-140 and target gene expression 
in other skeletal tissues. Whole genome transcriptomic datasets of skeletal tissues following 
various perturbations have been collated within SkeletalVis, a data portal for cross-species 
skeletal transcriptomics data (Soul et al. 2018). Although the majority of these studies do 
not directly assess miRNA expression, miRNAs that are located in the introns of protein 
coding genes, including miR-140, and are frequently co-regulated with their host gene 
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(Franca et al. 2016). A number of studies have utilised host-gene expression to predict the 
gene targets of intronic miRNAs through a consistent negative correlation in expression 
(Gennarino et al. 2009; Radfar et al. 2011). miR-140 is located in intron 16 of WWP2, with 
expression of the miR and an abundant isoform of WWP2 (transcript variant 2) controlled by 
a common promoter (Yamashita et al. 2012). WWP2 was therefore used as a surrogate for 
miR-140 expression. 
 
Of the 779 skeletal gene expression responses within SkeletalVis, 124 contained a significant 
alteration (adjusted p-value <0.05, no fold change cut off) in WWP2 expression. The change 
in WWP2 expression (as a surrogate for miR-140 expression) was plotted against the 
average fold change of predicted miRNA isomiR targets for each study. Using regression 
analysis we identified a significant  inverse relationship between WWP2 and miR-140-5p 
(Figure 6A; r2=0.38, p=3.08x10-14) and miR-140-3p.1, predicted targets (Figure 6B; r2=0.16, 
p=5.46x10-6). There was a minimal inverse relationship between WWP2 and miR-140-3p.2 
predicted targets (Figure 6C; r2=0.05, p=0.012) or randomly selected genes (Figure 6D). We 
then divided the studies into two; those where WWP2 significantly decreased and those 
where WWP2 significantly increased. The average target log2FC of predicted miR-140-5p, 
miR-140-3p.1 and miR-140-3p.2 targets was significantly higher in studies where WWP2 
decreased than studies where WWP2 increased (Supplemental Figure S6A). To determine if 
miR-140-5p, miR-140-3p.1 and miR-140-3p.2 targets are regulated in a similar way in each 
study, we correlated log2FC for miR-140-5p, miR-140-3p.1 and miR-140-3p.2 targets for all 
studies (Supplemental Figure S6B). Average log2FC for miR-140-5p targets correlated most 
strongly with average log2FC for miR-140-3p.1 targets (Supplemental Figure S6B). The 
direction of target FC tends to be in the opposite direction to WWP2 FC (Supplemental 
Figure S6B). Thus, where WWP2 expression changes the expression of predicted miR-140 
targets have a tendency to change in the opposite direction. 
 
In addition to average log2FC of predicted targets, we also investigated the percentage of 
predicted targets that increased or decreased within each of the studies. Within studies 
where WWP2 expression increased there was generally a larger percentage of predicted 
miR-140-5p and miR-140-3p.1 targets within downregulated genes than within upregulated 
genes, this was not true for miR-140-3p.2 (Figure 6E-H). For the contrary, when WWP2 
expression decreased, there was generally a larger percentage of miR-140-5p targets within 
upregulated genes than within downregulated genes, however there was little evidence of 
this for miR-140-3p.1 or miR-140-3p.2(Figure 6E-H).  Within Mir140 null mice (large 
symbols), where WWP2 expression was not altered, the percentage of targets within the 
upregulated genes is greater than the percentage of targets within downregulated genes 
(Figure 6E-H).  
 
Next we calculated ‘Target Enrichment (up/down)’ by dividing the percentage of targets 
within upregulated genes by those within the downregulated genes, for each of the studies 
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(a value >1 indicates more targets within upregulated whereas a value <1 indicates more 
targets within downregulated genes). Target enrichment for miR-140-5p and miR-140-3p.1 
was significantly higher in studies where WWP2 decreased than in studies where WWP2 
increased (Supplemental Figure S6C). Similar to the log2FC analysis, the enrichment for miR-
140-5p targets correlated most strongly with enrichment for miR-140-3p.1 targets 
(Supplemental Figure S6D).  
 
These data indicate that when WWP2 expression increases, both miR-140-5p and miR-140-
3p.1 predicted targets are repressed. Furthermore, they also indicate that miR-140-3p.2, 
which contains the miRBase annotated seed sequence, has a less significant biological effect 
on gene expression than either miR-140-5p or miR-140-3p.1. 
 
To further refine prediction of putative direct miR-140 targets, we investigated the overlap 
between four criteria; TargetScan predicted targets, genes downregulated following 
overexpression in human chondrocytes, genes upregulated in mice lacking the Mir140 locus, 
and genes upregulated during MSC chondrogenesis. There were 3, 3 and 0 genes matching 
all of these criteria for miR-140-5p, miR-140-3p.1 and miR-140-3p.2, respectively 
(Supplemental Figure S7A, Supplemental Table S9). ABCA1 was common to both miR-140-5p 
and miR-140-3p.1. Furthermore, ABCA1 was inversely correlated with WWP2 across 
multiple skeletal datasets, with the inverse correlation being strongest in cartilage 
experiments (Supplemental Figure S7B), where miR-140 expression is highest.   
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DISCUSSION 
 
IsomiRs of miR-140-3p have previously been detected in chondrocytes (Haseeb et al. 2017), 
breast cancer cell lines (Salem et al. 2016) and endometrial tissue (Krawczynski et al. 2015), 
and are now recognised in TargetScan 7.2 (Agarwal et al. 2015b). In TargetScan and this 
study, miR-140-3p.2 refers to the miRNA sequences with the seed of the original miRBase 
annotation and miR-140-3p.1 refers to the miRNA sequences with the seed of the newly 
identified isomiR. This study focuses upon the impact of seed sequence (5´isomiRs), further 
investigation is therefore required to understand the role of 3´ isomiRs of miR-140-3p. 
miRBase does not currently include specific annotation for isomiRs. In addition to miR-140-
3p isomiRs, we detected isomiRs for a number of other miRNAs in cartilage, including miR-
455, which is also now recognised in TargetScan 7.2 (Agarwal et al. 2015b). Sequence 
analysis of the miR-1246 isomiR, suggests it may in fact be miR-1290. According to miRBase 
these two miRNAs are transcribed from two separate loci on chromosome 2 and 1, 
respectively. However, Mazieres et al. (Mazieres et al. 2013), suggest miR-1246 and miR-
1290 are processed from a common transcript (RNU2), which explains their similar 
sequence and expression pattern during chondrogenesis (Barter et al. 2015). Many of the 
other detected cartilage isomiRs can be transcribed from more than one genomic location 
(hsa-mir-199a-3p, hsa-mir-199b-3p, hsa-mir-29b, hsa-mir-101, hsa-mir-320c, hsa-mir-103b), 
raising the possibility that each genomic location gives rise to only one mature miRNA, 
which are then perceived as isomiRs. 
 
Primary miRNA transcripts are processed to pre-miRNAs in the nucleus by DROSHA (a dsRNA 
nuclear type III endoribonuclease) facilitated by DGCR8, and subsequently cleaved in the 
cytoplasm by DICER to generate functionally mature miRNAs molecules.  IsomiRs are 
generated because both DICER and DROSHA process miRNA precursors imprecisely 
generating miRNA variants with several plus/minus nucleotides at the 5´ and/or 3´ (Neilsen 
et al. 2012). In addition, miRNAs can also be post-transcriptionally adenylated or uridylated,  
which could modify miRNA targeting properties and/or their stability (Burroughs et al. 2010; 
Marzi et al. 2016). The importance of endogenously expressed 5´ isomiRs has been 
demonstrated by Chiang et al. (Chiang et al. 2010), where they showed deletion of miR-223 
in mouse neutrophils (Baek et al. 2008), resulted in an increase in expression of predicted 
targets of a lesser expressed 5´ isomiR of the microRNA. Although it is established 5´ isomiRs 
can regulate gene expression, the functional reason for their presence is still debated. 
5´isomiRs of a given microRNA can have highly over-lapping targets, potentially increasing 
the specificity of regulation of a particular pathways (Cloonan et al. 2011; Llorens et al. 
2013). However, 5´ isomiRs can also increase a microRNAs target repertoire (Tan et al. 
2014). Manzano et al., suggest these apparent discrepancies are dependent upon the 
presence or absence of a U at position 2 of the longer isomiR sequence (Manzano et al. 
2015). miR-140-3p.2, the longest 5´ isomiR of miR-140-3p, does not possess a U at position 
2, which would suggest miR-140-3p.1 and miR-140-3p.2 have divergent target repertoires, 
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decreasing their effect on any single target (Manzano et al. 2015). Although not directly 
studied here, 3´isomiRs are widespread, with 3´ adenine additions being most common and 
reported to decrease the targeting ability of the miRNA (Burroughs et al. 2010). Some of the 
miR-140-3p isomiRs with the same seeds as miR-140-3p.1 and miR-140-3p.2 have 3´ 
adenine additions, which in combination with divergent 5´isomiRs may account for the poor 
target repression by miR-140-3p.1 and miR-140-3p.2 compared with miR-140-5p. 
Interestingly, there is an inverse correlation between the ability to repress targets (miR-140-
5p>miR-140-3p.1>miR-140-3p.2) and expression in cartilage (miR-140-3p.2>miR-140-
3p.2>miR-140-5p).  
 
A mutation within miR-140-5p has recently been identified as causing a human skeletal 
dysplasia (Grigelioniene et al. 2019b). Mice with the corresponding miR-140-5p mutation 
phenocopy the human situation and display a loss of miR-140-5p target repression (in rib 
chondrocytes). This is thought to contribute to the phenotype since the expression of miR-
140-3p.1 and miR-140-3.2 were not affected by the mutation. Interestingly though, the 
phenotypes of the miR-140-5p mutant mice and MIR140 null mice show some differences, 
which could perhaps be accounted for by the latter animals lacking miR-140-3p and the 
isomiRs described here.  
 
Here we identify discrete targets for miR-140-3p.1 and miR-140-3p.2. LIPA, a cholesterol 
ester hydrolase, is a target of miR-140-3p.1 but not miR-140-3p.2. LIPA expression 
decreases during chondrocyte development in human (Wu et al. 2013), consistent with high 
miR-140-3p.1 expression in chondrocytes. SDC4 (Syndecan-4), a target of miR-140-3p.2 but 
not miR-140-3p.1, has been implicated in osteoarthritis progression through activation of 
ADAMTS5 (Echtermeyer et al. 2009), suggesting SDC4 suppression by miR-140-3p.2 may 
maintain a healthy cartilage phenotype. HMGCR and HMGCS1 have now been identified as 
targets of miR-140-3p.1 in breast cancer cells (Bhardwaj and Cancer … 2018), however their 
expression was not repressed by miR-140-3p.1 in human chondrocytes, indicating miR-140 
isomiRs act in a tissue-specific manner. Even where repression was determined, the effects 
of miR-140-3p.1 and miR-140-3p.2 were relatively small (up to ~25% repression) when 
compared to the effects of miR-140-5p on a previously published miR-140-5p direct target, 
FZD6 (~60% repression) (Barter et al. 2015). Furthermore, contra to the expected miR-140-
3p.1 repression of targets, miR-140-3p.1 increased luciferase for the MARCKSL1, KIAA1199 
and MAPILC3A 3´UTR constructs, possibly suggesting stabilisation of transcript, as previously 
described for miR-322 and MEK1 (Bluhm et al. 2017). 
The target repertoire of miR-140-3p.1 and miR-140-3p.2 are vastly different, due to 
established miRNA target interaction rules. The only shared binding motif is ‘CUGUGG’, 
which can be recognised by miR-140-3p.1 as a 6merBS (CUGUGG), or by miR-140-3p.2 as a 
7m8-BS or 8mer-BS if followed by U or UA, respectively (CUGUGGU or CUGUGGUA) (Figure 
2A).  Indeed the miR-140-3p.1 6merBS (CUGUGG) was the most enriched miR-140-3p.1 
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motif following miR-140-3p.2 transfection (Figure 3E; red line in bottom right), indicating 
miR-140-3p isomiRs act according to traditional miRNA targeting rules. Other types of 
miRNA binding sites such as 3´compensatory binding (Grimson et al. 2007) may be shared 
between miR-140-3p.1 and miR-140-3p.2, but are less common and more difficult to 
predict. 
 
Analysis of miRNA target interactions within published skeletal data sets, using the WWP2 
host gene as a surrogate for miRNA expression, along with directly overexpressing the 
miRNAs and observing changes in gene expression, suggests these types of analyses can 
improve miRNA target prediction within skeletal tissues. Caution must however be taken as 
WWP2 and miR-140 can display tissue specific expression (Yamashita et al. 2012), 
furthermore, miRNA are often co-expressed with their targets as part of a larger more 
complex network (Cora et al. 2017). This type of co-expression may account for the studies 
where a correlation, rather than an inverse correlation, between WWP2 and miR-140 
targets was observed. Where an inverse correlation was observed between WWP2 and miR-
140 predicted targets this was greatest within cartilage. Together, these data indicate the 
miR-140-3p isomiR miR-140-3p.1 can function to down-regulate transcript expression in 
vitro and in vivo.  
 
In conclusion, analysis of human cartilage sRNA-seq identified an abundant isomiR to miR-
140-3p, miR-140-3p.1. Functional analysis in human and murine chondrocytes and analysis 
of published skeletal datasets suggests the newly identified isomiR is more effective than 
the original miR-140-3p annotated in miRBase. These data suggest the function of miR-140-
3p, which has previously been largely ignored, should be revisited.      
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MAIN FIGURE LEGENDS 
Figure 1. miR-140-3p isomiRs are abundantly expressed in cartilage. (A) Pie chart 
illustrating the relative abundance of all miRNAs expressed in cartilage, data combines 
isomiR and canonical reads for each miRNA. (B) Pie chart illustrating the isomiR type for all 
reads aligned to miR-140-3p. (C) Pie chart illustrating seed sequences for all reads aligned to 
miR-140-3p, >99% of reads have one of two seed sequences; ACCACAG (blue) and CCACAGG 
(red). (D) Pie chart of the percentage of templated and non-templated reads for miR-140-3p 
within cartilage. (E) Histogram of all sequencing reads aligned to miR-140-3p in cartilage. (F) 
Histogram of sequencing reads aligned to miR-140-3p, whose 5’ end is as indicated in 
miRBase. (G) Histogram of sequencing reads aligned to miR-140-3p, whose 5’ end is one 
nucleotide shorter than indicated in miRBase. (H) Bar chart indicting the sequences and 
number of reads that contribute to each of the two seed sequences. Individual bars 
represent total read number from 3 separate individuals. (I) qRT-PCR for miR-140-3p.1 and 
miR-140-3p.2. Assays designed to detect each isomiR are able to distinguish between miR-
140-3p.1 and miR-140-3p.2 spike-ins (2-fold serial dilution) and detect high expression of 
each isomiR in cartilage (2-fold serial dilution). 
 
Figure 2. miR-140-3p.1 and miR-140-3p.2 are predicted to have distinct targets. (A) 
Schematic illustrating the sequences of miRBase miR-140-3p, miR-140-3p.1, miR-140-3p.2 
and miR-140-5p and their potential binding sites within target mRNAs using the TargetScan 
categorisation. (B) Venn diagram illustrating little cross over of targets predicted by 
TargetScan 7.2 for miR-140-3p.1, miR-140-3p.2 and miR-140-5p.  
 
Figure 3. Identification and validation of miR-140-3p.1 and miR-140-3p.2 targets in human 
chondrocytes. (A) qRT-PCR for miR-140-3p.1 and miR-140-3p.2 following transfection of 
either control mimic, miR-140-3p.1 mimic or miR-140-3p.2 mimic for 48h. (B) PCA of whole 
genome micro-array following transfection of mimics described in (A), (140.1= miR-140-3p.1 
and 140.2=miR-140-3p.2). (C) Heat map of whole genome micro-array following transfection 
of mimics as described in (A) (140.1= miR-140-3p.1 and 140.2=miR-140-3p.2). (D) Venn 
diagram indicating the number of genes downregulated following overexpression of miR-
140-3p.1 and miR-140-3p.2. (E) Enrichment analysis using Sylamer for 3´UTR mRNA motifs 
complementary to either miR-140-3p.1 or miR-140-3p.2 seed sequences in genes whose 
expression decreased following transfection of either  miR-140-3p mimic, miR-140-3p.1 
mimic or miR-140-3p.2 mimic. (F) Gene expression changes of miR-140-3p.1 (only.1; red 
triangles), miR-140-3p.2 (only.2; blue diamonds) or miR-140-3p.1 and miR-140-3p.2 
(common; black squares) predicted targets following transfection of either miR-140-3p.1 
mimic or miR-140-3p.2 mimic. (G-I) 3´UTR luciferase reporters for miR-140-3p.1 and miR-
140-3p.2 putative targets. *, ** or *** indicate level of significance (p<0.05, 0.01 or 0.001, 
respectively) of either miR-140-3p.1 or miR-140-3p.2 to control. # indicates level of 
significance (p<0.05, 0.01 or 0.001, respectively) between miR-140-3p.1 and miR-140-3p.2.  
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Figure 4. Evidence for functional miR-140-3p.1 and miR-140-3p.2 in mouse cartilage. (A) 
Pie chart illustrating the fraction of miR-140-3p reads with canonical 5´ and 3´ ends (grey), 
canonical 5´ and either shorter or longer 3´ (blue), canonical 3´ and either shorter or longer 
5´ (green), either shorter or longer 5´ and either shorter or longer 3´ (red). (B) As in (A) with 
miR-140-3p.1 and miR-140-3p.2 indicated in dark red and dark blue respectively. (C)  Bar 
chart indicting number of reads that contribute to (B). (D) % of genes that are predicted 
targets of either a miR-140-5p (green), miR-140-3p.1 (red) or miR-140-3p.2 (blue), in genes 
whose expression decrease, does not change or increase following KO of miR-140 in mice. 
(E) Median fold change (FC) of all genes that are predicted targets of either a miR-140-5p 
(green), miR-140-3p.1 (red) or miR-140-3p.2 (blue) following KO of miR-140 in mice. (F) 
Cumulative fraction plot of all genes (black), miR-140-5p (green), miR-140-3p.1 (red) or miR-
140-3p.2 (blue) predicted targets, for genes ordered from most decreased expression to 
most increased expression in Mir140 null mice. Inset: Fraction at a cut-off of log2FC -1. (G) 
Sylamer analysis for Mir140 null mice; the 100 most enriched 7mers are shown with 7m8 
binding sites for miR-140-5p (green), miR-140-3p.1 (red) and miR-140-3p.2 (blue) 
highlighted. 
 
Figure 5. Evidence for miR-140-3p.1 and miR-140-3p.2 function during human MSC 
chondrogenesis. Re-analysis of data from Barter et al [10] for human MSC differentiation to 
cartilage. (A) Changes in gene expression for eight MSC and chondrogenic markers. (B) 
Mean fold change of all genes that are predicted targets of either a miR-140-5p (green), 
miR-140-3p.1 (red) or miR-140-3p.2 (blue) during MSC chondrogenesis. (C) Sylamer analysis 
for a miR-140-5p (green), miR-140-3p.1 (red) and miR-140-3p.2 (blue) 7m8 seed sequences.  
 
Figure 6. Correlation of MIR140 locus host gene WWP2 with miR-140 target genes in 
SkeletalVis transcriptomic datasets. (A-D) Correlation analysis of WWP2 and predicted 
miRNA target expression in 124 pre-existing transcriptome-wide comparisons (both human 
and mouse). Scatter graph of WWP2 log2FC plotted against the average log2FC for genes 
predicted to be either a target of miR-140-5p (A), miR-140-3p.1 (B), miR-140-3p.2 (C) or 500 
random genes (D), p-value calculated from linear regression analysis. (E-H) Percentage of 
miR-140-5p (E), miR-140-3p.1 (F) or miR-140-3p.2 (G) predicted targets and 500 random 
genes (H) within the significantly up or downregulated genes for data sets where WWP2 
expression significantly changes. The percentage of targets within upregulated (purple), no 
change (black) or downregulated (orange) transcripts is plotted against log2FC WWP2. Large 
icons represent enrichment of miR-140-5p, miR-140-3p.1 and miR-140-3p.2 predicted 
targets in up- and downregulated genes within rib cartilage of Mir140 null mice, where 
Wwp2 expression does not change. 
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SUPPLEMENTAL FIGURE LEGENDS 
Supplemental Figure S1. Cartilage miRNAs which have abundant 5´ isomiRs. Twenty-nine 
miRNAs with isomiRs that account for more than 5% of the reads for that miRNA and the 
number of isomiR reads is greater than 100. miR-1246 isomiR (read count 99) is also shown. 
5´ start position of each isomiR relative to the miRBase annotation is shown: the addition of 
a nucleotide is designated as ‘+1’ and the loss as ‘-1’, ‘0’ represents reads of the miRBase 
annotation. Histogram indicates read count.  
Supplemental Figure S2. Analysis of published RNA-seq. miR-140-3p.1 and miR-140-3p.2 
were present in multiple sRNA-seq data including; melanoma (Stark et al. 2010), cervix 
(Witten et al. 2010), lymphocytes (Kuchen et al. 2010), and following immunoprecipitation 
of Argonaute (AGO) proteins (Burroughs et al. 2011). Sequences were designated either 
miR-140-3p.1 or miR-140-3p.2 based upon seed sequence.  The isomiRs were also 
approximately equally detected in CLEAR-CLIP data from mouse cortex tissue (Moore et al. 
2015), however their low expression in this tissue did not allow for target prediction from 
the covalently ligated mRNAs.  
 
Supplemental Figure S3. Pathway analysis of differentially expressed genes using g-Profiler. 
Pathway analysis of the 237 genes differentially expressed between miR-140-3p.1 and miR-
140-3p.2 transfected chondrocytes using g-Profiler. Significant gene ontology molecular 
function (G0:MF), biological processes (GO:BP) and Reactome (REAC) terms are shown. The 
adjusted p-values, distribution within terms between downregulation with each isomiR and 
the fraction of these genes that are also predicted targets of miR-140-3p.1 and miR-140-
3p.2 are depicted. Distribution of miR-140-3p.1 and miR-140-3p.2 TargetScan predicted 
targets (PT) are also shown.     
 
Supplemental Figure S4. IsomiR read count and enrichment score for all possible sequences 
derived from miR-140. (A) Read count for all 5´isomiRs encoded from the mouse miR-140 
stem loop according to miRBase. (B) Sylamer analysis of rib cartilage RNA from mice lacking 
miR-140 stem loop for 7m8 seed binding sites corresponding to every possible miRNA 
produced from the Mir140 locus. Histogram represents average enrichment score for each 
seed binding motif.   
 
Supplemental Figure S5. Validation of miR-140 null mouse model and rib chondrocyte RNA-
seq. (A) Deletion of Mir140 was attained using the CRISPR/-Cas9 system. The Mir140 locus 
was targeted in mouse zygotes using two crRNAs (blue line, protospacer adjacent motif 
(PAM) shown in red). This successfully deleted the Mir140 locus sequence depicted (KO 
mir140). (B)  Mice were bred to homozygosity with the genotype in wild-type, heterozygous 
and null mice confirmed through PCR of ear-notch genomic RNA. (C) Total RNA was 
extracted from rib chondrocytes of postnatal day 7 (P7) mice, reverse transcribed to cDNA 
and subjected to real time qRT-PCR analysis for gene expression of miR-140-5p and miR-
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140-3p (canonical). Values were normalised to U6 and plotted as mean ± standard error of 
the mean (SEM) (number of samples, WT=7, miR-140-/- =6). *** p≤0.001. (D) The RNA from 
several of the same samples as (C) was subjected to RNA-seq (n=4 for WT and miR-140-/-). 
Principle component analysis of length-scaled TPM (Transcripts Per Million) values 
segregated WT and KO (blue and red). (E) Heat map of the 1200 most differentially 
expressed genes.   
 
Supplemental Figure S6. Comparison of miR-140-5p, miR-140-3p.1 and miR-140-3p.2 target 
fold change and enrichment in studies where WWP2 expression either decrease or 
increases. (A) Average log2FC for miR-140-5p, miR-140-3p.1 and miR-140-3p.2 targets 
within studies where WWP2 expression either decreased for increased. (B) Correlation 
between average log2FC for miR-140-5p, miR-140-3p.1 and miR-140-3p.2 predicted targets 
for all studies where WWP2 expression changed. (C) Enrichment for miR-140-5p, miR-140-
3p.1 and miR-140-3p.2 targets within studies where WWP2 either decreased for increased. 
(D) Correlation between enrichment for miR-140-5p, miR-140-3p.1 and miR-140-3p.2 
predicted targets for all studies where WWP2 expression changed.  Studies where WWP2 
significantly decreased are shown in purple and increased shown in orange. For (B) and (C) 
symbol size if proportional to the level of WWP2 change in expression. The enrichment was 
calculated by dividing the percentage of targets within upregulated genes by the percentage 
of targets within downregulated genes for each study.  
 
Supplemental Figure S7. Overlap between human and mouse miR140 datasets. (A) overlap 
between predicted targets, genes downregulated following overexpression in human 
articular chondrocytes (HAC), genes upregulated in mice lacking the Mir140 locus and genes 
downregulated during human MSC chondrogenesis. Data represented as Venn diagram and 
‘UpSet’ plot. (B) Regression analysis of ABCA1 expression and WWP2 in multiple skeletal 
tissues, separated based on tissue type. 
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SUPPLEMENTAL TABLE LEGENDS 
Supplemental Table S1. Cartilage sRNA-seq. Cartilage sRNA-seq from 3 donors (c15, c16 
and c17). All sequences including isomiRs aligning to 990 mature miRNAs are shown with 
read count.   
Supplemental Table S2. Predicted targets. Predicted targets of miR-140-5p, miR-140-3p.1 
and miR-140-3p.2 by TargetScanHuman 7.2. Gene lists correspond to Venn diagram in figure 
2B. 
Supplemental Table S3. Human chondrocyte gene expression. Human chondrocyte gene 
expression changes following transfection of miRNA mimics: miR-140-3p.1 vs CON, miR-140-
3p.2 vs CON, miR-140-3p.1 vs miR-140-3p.2  
Supplemental Table S4. Human chondrocyte gene list. Gene lists from human 
chondrocytes: Genes decreased (down) with miR-140-3p.1 vs control, Genes decreased 
(down) with miR-140-3p.2 vs control, Genes decreased (down) with both miR-140-3p.1 and 
miR-140-3p.2 vs control, and genes significantly different between miR-140-3p.1 and miR-
140-3p.2 when directly compared.  
Supplemental Table S5. Human chondrocyte pathway analysis. Pathway analysis (PA) using 
DAVID for genes decreased with miR-140-3p.1, genes decreased with miR-140-3p.2 genes 
significantly different between miR-140-3p.1 and miR-140-3p.2.  
Supplemental Table S6. Mir140 KO mice gene expression. RNA-seq of mouse rib cartilage 
of Mir140 KO mice and WT control mice 
Supplemental Table S7. Mir140 KO mice gene lists. List of up and downregulated genes in 
Mir140 KO mice 
Supplemental Table S8. Mir140 KO mice pathway analysis. Pathway analysis using DAVID 
for genes upregulated in Mir140 KO mice 
Supplemental Table S9. Human vs mouse. Cross over between predicted targets, human 
chondrocyte data and mouse Mir140 KO data 
Supplemental Table S10. Oligonucleotides. Table of oligonucleotides used in this study. 
Targets of miR-140-3p.1 and miR-140-3p.2 used for cloning into pMiR-GLO by InFusion. 
Primers used for the generation and genotyping of miR-140-/- mice. 
 






